Filter Results:
(170)
Show Results For
- All HBS Web
(257)
- News (56)
- Research (170)
- Events (3)
- Multimedia (3)
- Faculty Publications (59)
Show Results For
- All HBS Web
(257)
- News (56)
- Research (170)
- Events (3)
- Multimedia (3)
- Faculty Publications (59)
Sort by
- 27 Feb 2018
- First Look
First Look at New Research and Ideas, February 27, 2018
percent increase in housing prices. Moreover, Yelp measures of local business activity provide leading indicators for housing price changes and help to forecast which neighborhoods are gentrifying. Download working paper:... View Details
Keywords: Sean Silverthorne
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace
- 21 Sep 2022
- Research & Ideas
You Don’t Have to Quit Your Job to Find More Meaning in Life
overpriced drugs (moral condition) or drove patients into debt by increasing prices (immoral condition). Only 19 percent of participants said Ariana’s life was meaningful when she drove patients into debt by... View Details
Keywords: by Shalene Gupta
- 07 Aug 2007
- First Look
First Look: August 7, 2007
products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. Purchase this note: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807050 ... View Details
Keywords: Martha Lagace
- 05 Dec 2016
- Research & Ideas
How The 2016 Presidential Candidates Misled Us With Truthful Statements
Another example is a TV ad that Hillary Clinton’s campaign ran last December, which included the following claim: “In the last seven years, drug prices have doubled.” One of the main purposes of the ad was... View Details
Keywords: by Dina Gerdeman
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- 25 Sep 2018
- First Look
New Research and Ideas, September 25, 2018
operations. Product failures are, therefore, likely to impact firms’ subsequent innovation activities. Using 13 years of Food and Drug Administration data, we examine the effects of firm and competitor medical device recalls on subsequent... View Details
Keywords: Dina Gerdeman
- 31 Mar 2023
- Research & Ideas
Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?
would make payments to health care providers on a risk-adjusted per-enrolled basis instead of a fee-for-service basis—as a tool to mitigate risks involved with centralized pricing and rate-setting. Evidence suggests that capitation can... View Details
- 25 Oct 2016
- First Look
October 25, 2016
insulate consumers from cost sharing, thereby undermining insurers’ ability to influence drug utilization. We study the impact of copay coupons on branded drugs first facing generic entry between 2007 and... View Details
Keywords: Sean Silverthorne
- 20 Oct 2011
- Research & Ideas
Getting the Marketing Mix Right
when a company attempts to move in on its market share, perhaps by offering price discounts. Since this strategy is viewed as more threatening, the competitor can be expected to retaliate with prejudice—often by firing off a campaign to... View Details
Keywords: by Dina Gerdeman
- 15 Nov 2018
- Book
Can the Global Food Industry Overcome Public Distrust?
JamesBrey Food is the largest segment of the global economy. It is also widely recognized as more critical for human health than any pharmaceutical drug on the planet. But significant changes in the industry are making people lose trust in many institutions involved in... View Details
- 29 Jan 2013
- First Look
First Look: Jan. 29
business units and improving their leadership skills. The CDC has adopted an innovative pricing structure. Rather than charging direct fees for these consulting services, it proposed to the client that it contract with the firm for five... View Details
Keywords: Sean Silverthorne
- 25 Aug 2003
- Research & Ideas
Why IT Does Matter
Radio-frequency identification devices for grocery stores, smart cards, and automated ordering systems for hospital physicians are all examples of new process targets that technologies will soon address. In the more distant future we will see the improved creation of... View Details
Keywords: by F. Warren McFarlan & Richard L. Nolan
- 29 Jan 2021
- Op-Ed
How Influencers, Celebrities, and FOMO Can Win Over Vaccine Skeptics
temporary price promotion strategy can create an act-now force related to the FOMO on the benefit. Any skepticism on pricing needs to heavily emphasize the cons of not taking the vaccine, such as the... View Details
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from agricultural farming. Harvard Business... View Details
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
worldwide pharmaceuticals spending, according to Food and Drug Administration Commissioner Mark McClellan.) One problem, several panelists noted, is that European healthcare systems do not reimburse the high View Details
- 09 Aug 2016
- First Look
August 9, 2016
spending in the United States, accounting for less than 1% of prescriptions filled but nearly 28% of drug spending. Whereas traditional (chemically synthesized, "small-molecule") drugs have... View Details
Keywords: Sean Silverthorne
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
according to panelists from the healthcare field and the pharmaceutical industry, is delivering drugs that are donated or available at reduced prices to patients who need them. Government Priorities Dr.... View Details
Keywords: by Julie Jette
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the problem of high View Details
Keywords: Sean Silverthorne
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
pharmaceutical firm B creates a drug that treats the same ailment and prepares to bring the drug to market. According to best estimates, this new competition will reduce the View Details
Keywords: by Max H. Bazerman